Senior insider sale
CFO at REVANCE THERAPEUTICS, INC. — senior position signals high conviction
$52.5K
9.50K shares
What this filing means
SCHILKE TOBIN plans to sell 9.50K shares of REVANCE THERAPEUTICS, INC. valued at approximately $52.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2024ACC: 0000950170-24-032487
Officer· CFO
Since Nov 2018
9.50K
Shares to sell
$52.5K
Approx. market value
9.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Vesting
Cash
3/15/2024
9.50KTotal acquired9.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2024 | RSU Vesting Cash | 9.50K | — |
| Total | 9.50K | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
9.50K
Market value
$52.5K
3/15/2024
Total
Units
9.50K
Value
$52.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/15/2024 | 9.50K | $52.5K | NASD | Planned |
| Total | 9.50K | $52.5K | ||